Imifoplatin
N/A
Report date: 2026/03/04 20:01:44
NME
Base Information
Drug NameImifoplatin
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[13]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesPhosplatin Therapeutics Llc
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesNational Cancer InstituteSciclone Pharmaceuticals International (Cayman) Development LtdLyophilization Technology Inc +[6]
Inactive CompaniesSciclone Pharmaceuticals
Active Indications +[10]
Inactive Indications